Display options
Share it on

Int J Angiol. 2013 Dec;22(4):213-22. doi: 10.1055/s-0033-1348884.

The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry.

The International journal of angiology : official publication of the International College of Angiology, Inc

Surya Dharma, Iwan Dakota, Isman Firdaus, Alexander J Wardeh, J Wouter Jukema

Affiliations

  1. Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
  2. Department of Cardiology, M.C. Haaglanden, The Hague, The Netherlands.
  3. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

PMID: 24436615 PMCID: PMC3830567 DOI: 10.1055/s-0033-1348884

Abstract

Real-world data on acute coronary syndrome (ACS) patients who received intra-aortic balloon pump (IABP) support are limited. The objective of this study was to evaluate the characteristics of ACS patients who received IABP support from a real-world ACS registry. Patients with ACS (N = 121) who received IABP support were enrolled. Characteristics of survivors and nonsurvivors were compared at 30 days. Mortality rate of patients with ACS who received IABP was 47%. The survivors (N = 64) had less often cardiogenic shock (p < 0.001), more often IABP usage as back-up for a revascularization procedure (p = 0.002), less often resuscitation (p = 0.043), and less mechanical ventilator support (p < 0.001) than nonsurvivors. The nonsurvivors had a significantly higher leukocyte count (p = 0.033), a higher serum creatinine level (p < 0.001), a higher blood sugar on admission (p = 0.001), higher creatine kinase MB levels (p = 0.002), and a higher serum uric acid level (p < 0.001), but significantly lower left and right ventricular function (p = 0.014 and p = 0.003, respectively) than survivors. At 30 days, non-ST elevation (STE)-ACS patients had lower mortality rate than ST segment elevation myocardial infarction patients (log-rank test, p < 0.001), and non-STE-ACS patients who had not suffered from cardiogenic shock showed the lowest mortality rate (log-rank test, p < 0.001). By multivariate analysis, a heart rate ≥ 100 beats per minute before IABP insertion was the strongest predictor of 30-day mortality (hazard ratio = 5.69; 95% confidence interval, 1.49 to 21.78; p = 0.011). In ACS patients presenting with either cardiogenic shock, resuscitated, or patients who needed mechanical ventilation suffered from high mortality, despite the use of IABP. IABP appears to be safe and tended to be favorable in noncardiogenic shock ACS patients, particularly non-STE-ACS. A heart rate of ≥ 100 beats per minute prior to IABP insertion was the strongest predictor of 30-day mortality.

Keywords: ACS; IABP; nonsurvivor; survivor

References

  1. Interact Cardiovasc Thorac Surg. 2009 Mar;8(3):310-5 - PubMed
  2. Eur Heart J. 2009 Feb;30(4):459-68 - PubMed
  3. J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63 - PubMed
  4. N Engl J Med. 1973 May 10;288(19):979-84 - PubMed
  5. J Am Coll Cardiol. 2001 Nov 1;38(5):1456-62 - PubMed
  6. N Engl J Med. 1999 Apr 15;340(15):1162-8 - PubMed
  7. JAMA. 2010 Aug 25;304(8):867-74 - PubMed
  8. Catheter Cardiovasc Interv. 2012 Feb 15;79(3):453-95 - PubMed
  9. Circulation. 1995 Feb 1;91(3):873-81 - PubMed
  10. Circulation. 1980 Nov;62(5):960-70 - PubMed
  11. Circulation. 2000 Oct 24;102(17):2031-7 - PubMed
  12. N Engl J Med. 1976 Dec 16;295(25):1404-13 - PubMed
  13. Lancet. 1986 Feb 22;1(8478):397-402 - PubMed
  14. Mayo Clin Proc. 2006 Aug;81(8):1034-40 - PubMed
  15. Circulation. 2006 Mar 21;113(11):e463-654 - PubMed
  16. Ann Thorac Surg. 1974 Jun;17(6):602-36 - PubMed
  17. Eur Heart J. 2012 Oct;33(20):2569-619 - PubMed
  18. JAMA. 1968 Jan 8;203(2):113-8 - PubMed
  19. N Engl J Med. 2012 Oct 4;367(14):1287-96 - PubMed
  20. Lancet. 1990 Jul 14;336(8707):71-5 - PubMed
  21. Circulation. 2004 Aug 31;110(9):e82-292 - PubMed
  22. JAMA. 2005 Jul 27;294(4):448-54 - PubMed
  23. N Engl J Med. 1993 Sep 2;329(10):673-82 - PubMed
  24. Arch Intern Med. 2003 Oct 27;163(19):2345-53 - PubMed
  25. Heart. 2006 Apr;92 Suppl 1:i19-26 - PubMed
  26. Eur Heart J. 2007 Jul;28(14):1709-16 - PubMed
  27. JAMA. 2007 Apr 18;297(15):1657-66 - PubMed
  28. Circulation. 2009 Mar 10;119(9):1211-9 - PubMed
  29. Ann Thorac Surg. 2002 Sep;74(3):746-51; discussion 751-2 - PubMed
  30. Heart. 1999 Jul;82(1):96-100 - PubMed

Publication Types